Tribune Invests $18M in Core & Main, Securing 8.74% of Q3 AUM
Tribune Investment Group acquired 335,000 Core & Main shares valued at $18.03 million during Q3, representing 8.74% of its 13F reportable assets. Core & Main’s Q3 sales rose 1.2% to $2.06 billion, net income climbed to $143 million with adjusted EPS of $0.89 and gross margin expanded to 27.2%.
1. Tribune Investment Group’s Strategic Entry
Tribune Investment Group LP initiated a new position in Core & Main during the third quarter, acquiring 335,000 shares with a market value of $18.03 million as of September 30. This transaction, disclosed in the firm’s November 13 SEC filing, marked Tribune’s 21st disclosed position and represented a significant commitment to Core & Main’s long-term infrastructure distribution business.
2. Position’s Weight in Tribune’s Portfolio
The Core & Main holding accounted for 8.74% of Tribune’s 13F reportable assets under management as of quarter-end, ranking it as the largest single investment in the firm’s reported portfolio. By comparison, the next three largest positions each represented between 6.4% and 8.6% of AUM, underscoring Tribune’s conviction in Core & Main relative to other industrial and infrastructure names.
3. Solid Third-Quarter Operational Metrics
In its fiscal third quarter, Core & Main reported sales of $2.06 billion, a 1.2% year-over-year increase driven primarily by acquisitions. Gross margin expanded to 27.2%, while net income climbed to $143 million and adjusted EPS reached $0.89. Operating cash flow for the period totaled $271 million, reflecting the company’s consistent cash generation in its distribution-focused model.
4. Capital Return and Long-Term Outlook
Following the quarter, Core & Main repurchased $50 million of its common stock and secured board approval for an additional $500 million buyback authorization. The company’s leading position in water, wastewater and fire protection infrastructure, combined with disciplined capital deployment and steady demand from municipal and construction end markets, supports a multi-year growth thesis that aligns with patient institutional investors’ time horizons.